[Bone turnover and early parenteral calcium supply in preterm infants]
1The Affiliated Children's Hospital, College of Medicine, Zhejiang University Hangzhou 310003, China.
Insights
Preterm infants show active bone turnover compared to term infants. Early calcium supplementation increases calcium levels but does not affect bone formation or resorption markers.
Area of Science:
- Biochemistry
- Pediatrics
- Neonatology
Context:
- Preterm infants exhibit distinct biochemical profiles of bone turnover compared to term infants.
- Bone metabolism is crucial for growth and development in neonates.
Purpose:
- To investigate dynamic changes in bone turnover markers in preterm infants.
- To evaluate the impact of early parenteral calcium supply on these markers.
Summary:
- Serum alkaline phosphatase (AKP) and carboxyterminal telopeptide type I collagen (ICTP) were elevated in preterm infants at 24 hours, correlating negatively with gestational age and birth weight.
- Serum osteocalcin (OC) was lower in preterm infants initially but normalized by day 11.
- Parenteral calcium supply increased serum and urine calcium but did not alter OC or ICTP levels, with normal renal function observed.
Impact:
- Early life calcium supplementation in preterm infants primarily affects calcium levels, not bone formation or resorption markers.
- Understanding bone turnover dynamics is essential for optimizing neonatal care and long-term skeletal health.
Objective:
To explore the dynamic change in biochemical markers of bone turnover in preterm infants and the effect of early parenteral calcium supply.
Methods:
Forty preterm infants were divided into parenteral calcium supply group and control group. Blood and urine samples were collected at 24 h and 11 d after birth. Serum osteocalcin (OC) was measured with ELISA, serum carboxyterminal telopeptide type I collagen (ICTP) with radioimmunoassay, serum alkaline phosphatase (AKP), calcium, phosphate, and urine calcium, phosphate, creatinine with automatic biochemical analyzer. Blood samples were also collected from 22 term infants as control. Calcium gluconate (10%, 4 ml/kg x d(-1)) was administered intravenously in parenteral calcium supply group.
Result:
At 24 h, serum AKP, ICTP [(147.86+/- 44.87)IU, (57.36+/- 6.34)micro g/L] in preterm infants were significantly higher than those [(147.86+/- 44.87)IU, (57.36+/- 6.34)micro g/L] in term infants, and negatively correlated with gestational age and birth weight (r =-0.528, P<0.01; -0.614, P< 0.01), but serum OC [(648.77+/- 238.89) nmol/L] in preterm infants was lower than that [(851.68+/- 238.69)nmol/L] of term infants, and positively correlated with gestational age and birth weight (r=0.359, P< 0.05; 0.376, P< 0.01). At 11 day, serum OC [947.25+/- 335.47)nmol/L] in preterm infants was markedly elevated and reached the level of term infants [(941.65+/- 297.28)nmol/L], but serum ICTP [(65.44+/- 6.24)micro g/L] in preterm infants was higher than that [(57.10+/- 3.48)micro g/L] in term infants all along. Serum AKP [(246.00+/-66.64)IU] in parenteral calcium supply group was higher than that [(206.53+/- 53.9)IU] in the control group. There were no significantly differences in serum OC and ICTP between parenteral calcium supply group and the control group. Calcium in serum and urine was elevated, phosphate in serum and urine was reduced in the parenteral calcium supply group. Urine analysis and kidney ultrasounds were normal.
Conclusion:
There is active bone formation and bone resorption in preterms as compared with terms. Alone parenteral calcium supply during early life can not increase formation of bone protein or decrease degradation of bone collagen, but can elevate serum calcium and urine calcium levels. Hematuria and renal calcification were not found in short duration.
Related Concept Videos
The Bone Matrix
Bone Formation by Intramembranous Ossification
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Skeleton and Calcium Homeostasis


